MENU

KPTI Stock Tickeron detected bullish Stock Pattern: Cup-and-Handle KPTI on December 08, 2025, netting in a 26.22% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+26.22% Gain from a Successful pattern Cup-and-Handle
KPTI - Karyopharm Therapeutics Inc.
Tickeron
Ticker: KPTI
Company: Karyopharm Therapeutics
Gain: +26.22%
Confirmed: 12/08/25
Succeeded: 12/22/25
Total length: 32 days

On November 20, 2025, A.I.dvisor detected a Cup-and-Handle Pattern (Bullish) for Karyopharm Therapeutics Inc. (KPTI, $5.76). On December 08, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $7.50. 14 days later, on December 22, 2025, KPTI reached the target price resulting in a +2 for traders who took a long position in the stock.

KPTI's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for KPTI turned positive on December 04, 2025. Looking at past instances where KPTI's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 09, 2025. You may want to consider a long position or call options on KPTI as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

KPTI moved above its 50-day moving average on December 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for KPTI crossed bullishly above the 50-day moving average on December 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KPTI advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 110 cases where KPTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KPTI moved out of overbought territory on December 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KPTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KPTI broke above its upper Bollinger Band on December 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (26.614). P/E Ratio (0.000) is within average values for comparable stocks, (51.532). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.447) is also within normal values, averaging (310.546).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KPTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KPTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KPTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com